Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1352925-63-3

Post Buying Request

1352925-63-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1352925-63-3 Usage

Description

Ethyl 4,6-dihydroxypyridazine-3-carboxylate is a chemical compound with the molecular formula C8H10N2O4. It is a derivative of pyridazine, characterized by the presence of dihydroxypyridazine and carboxylate functional groups. These functional groups endow it with versatile reactivity, making it a valuable building block or intermediate in the synthesis of pharmaceuticals and agrochemicals. Its structural features also suggest potential pharmacological properties, warranting further research for applications in medicinal chemistry.

Uses

Used in Pharmaceutical Synthesis:
Ethyl 4,6-dihydroxypyridazine-3-carboxylate is used as a building block for the synthesis of various pharmaceuticals. Its dihydroxypyridazine and carboxylate functional groups facilitate chemical reactions that can lead to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Synthesis:
In the agrochemical industry, ethyl 4,6-dihydroxypyridazine-3-carboxylate is utilized as an intermediate in the production of agrochemicals. Its chemical properties allow for the creation of compounds that can be used in crop protection and other agricultural applications.
Used in Medicinal Chemistry Research:
Due to its structural features, ethyl 4,6-dihydroxypyridazine-3-carboxylate is used as a subject of research in medicinal chemistry. Scientists explore its potential pharmacological properties and how it can be modified or combined with other compounds to develop new medications or enhance existing ones.
While the provided materials do not specify particular applications in different industries beyond the general categories of pharmaceuticals and agrochemicals, the compound's versatility suggests it may find use in a variety of chemical and biological research areas, pending further exploration and development.

Check Digit Verification of cas no

The CAS Registry Mumber 1352925-63-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,2,9,2 and 5 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1352925-63:
(9*1)+(8*3)+(7*5)+(6*2)+(5*9)+(4*2)+(3*5)+(2*6)+(1*3)=163
163 % 10 = 3
So 1352925-63-3 is a valid CAS Registry Number.

1352925-63-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 4-hydroxy-6-oxo-1H-pyridazine-3-carboxylate

1.2 Other means of identification

Product number -
Other names 4,6-dihydroxy-pyridazine-3-carboxylic acid ethyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1352925-63-3 SDS

1352925-63-3Relevant articles and documents

SULFONE PYRIDINE ALKYL AMIDE-SUBSTITUTED HETEROARYL COMPOUNDS

-

Paragraph 0426-0428, (2019/06/07)

Compounds having the following formula I: or a stereoisomer or pharmaceutically-acceptable salt thereof, where R1, R2, R3, R4, and R5 are as defined herein, are useful in the modulation of IL-12, IL-23 and/or IFNα, by acting on Tyk-2 to cause signal transduction inhibition.

ALPHA-D-GALACTOSIDE INHIBITORS OF GALECTINS

-

, (2016/08/23)

The present invention relates to a compound of the general formula (1). wherein the pyranose ring is a-D-galactopyranose, A is selected from The compound of formula (1) is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore the present invention concerns compounds for use in a method of treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.

AMIDE-SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHα RESPONSES

-

, (2014/05/24)

Compounds having the following formula I: or a stereoisomer or pharmaceutically-acceptable salt thereof, where R1, R2, R3, R4, and R5 are as defined herein, are useful in the modulation of IL-12, IL-23 and/or IFNa, by acting on Tyk-2 to cause signal transduction inhibition.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1352925-63-3